第713号委员会意见:促进胎儿成熟的产前皮质类固醇治疗
该委员会意见推荐对孕24 0/7周至33 6/7周、7天内可能早产的孕妇使用单疗程皮质类固醇,包括胎膜已破和多胎妊娠者;可考虑用于孕23 0/7周起、基于家庭复苏决策的孕妇;可考虑用于孕34 0/7周至36 6/7周、7天内可能早产且未接受过产前皮质类固醇者;建议对孕不足34 0/7周、7天内可能早产且前次用药超过14天者考虑单次重复疗程;若临床需要,补救疗程可早至前次给药后7天提供;应支持对宫内皮质类固醇暴露后长期结局的持续监测;鼓励采用质量改进策略优化适时适当的产前皮质类固醇给药。
要点
- 推荐孕24 0/7–33 6/7周、7天内可能早产者使用单疗程皮质类固醇,包括胎膜已破和多胎妊娠。
- 孕23 0/7周起、基于家庭复苏决策可考虑使用,不论胎膜破裂状态和胎儿数量。
- 孕34 0/7–36 6/7周、7天内可能早产且未接受过产前皮质类固醇者可考虑倍他米松。
核心结论
- 产前皮质类固醇是改善新生儿结局最重要的产前治疗之一,推荐对符合条件的孕妇使用单疗程,并支持长期结局监测和质量改进策略。
研究设计与样本
- 美国妇产科医师学会(Obstet Gynecol)发布的第713号委员会意见。
主要发现
- 推荐孕24 0/7周至33 6/7周、7天内可能早产者使用单疗程皮质类固醇,包括胎膜已破和多胎妊娠者。
- 可考虑用于孕23 0/7周起、7天内可能早产者,基于家庭复苏决策,不论胎膜破裂状态和胎儿数量。
- 可考虑用于孕34 0/7周至36 6/7周、7天内可能早产且未接受过产前皮质类固醇者使用倍他米松。
- 建议对孕不足34 0/7周、7天内可能早产且前次产前皮质类固醇给药超过14天者考虑单次重复疗程。
- 若临床需要,补救疗程可早至前次给药后7天提供。
关键数值与推荐
- 推荐孕24 0/7–33 6/7周、7天内可能早产者使用单疗程皮质类固醇,包括胎膜已破和多胎妊娠。
- 可考虑孕23 0/7周起、7天内可能早产者使用,基于家庭复苏决策,不论胎膜破裂状态和胎儿数量。
- 可考虑孕34 0/7–36 6/7周、7天内可能早产且未接受过产前皮质类固醇者使用倍他米松。
- 建议孕不足34 0/7周、7天内可能早产且前次产前皮质类固醇给药超过14天者考虑单次重复疗程。
- 补救疗程可早至前次给药后7天提供,若临床需要。
临床怎么用
- 对孕24 0/7–33 6/7周、7天内可能早产者使用单疗程皮质类固醇,包括胎膜已破和多胎妊娠。
- 对孕23 0/7周起、7天内可能早产者,基于家庭复苏决策可考虑使用,不论胎膜破裂状态和胎儿数量。
- 对孕34 0/7–36 6/7周、7天内可能早产且未接受过产前皮质类固醇者可考虑倍他米松。
- 对孕不足34 0/7周、7天内可能早产且前次产前皮质类固醇给药超过14天者建议考虑单次重复疗程。
- 若临床需要,补救疗程可早至前次给药后7天提供。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Corticosteroid administration before anticipated preterm birth is one of the most important antenatal therapies available to improve newborn outcomes. A single course of corticosteroids is recommended for pregnant women between 24 0/7 weeks and 33 6/7 weeks of gestation who are at risk of preterm delivery within 7 days, including for those with ruptured membranes and multiple gestations. It also may be considered for pregnant women starting at 23 0/7 weeks of gestation who are at risk of preterm delivery within 7 days, based on a family's decision regarding resuscitation, irrespective of membrane rupture status and regardless of fetal number. Administration of betamethasone may be considered in pregnant women between 34 0/7 weeks and 36 6/7 weeks of gestation who are at risk of preterm birth within 7 days, and who have not received a previous course of antenatal corticosteroids. A single repeat course of antenatal corticosteroids should be considered in women who are less than 34 0/7 weeks of gestation who are at risk of preterm delivery within 7 days, and whose prior course of antenatal corticosteroids was administered more than 14 days previously. Rescue course corticosteroids could be provided as early as 7 days from the prior dose, if indicated by the clinical scenario. Continued surveillance of long-term outcomes after in utero corticosteroid exposure should be supported. Quality improvement strategies to optimize appropriate and timely antenatal corticosteroid administration are encouraged.
引用
- Committee Opinion No. 713: Antenatal Corticosteroid Therapy for Fetal Maturation. Obstet Gynecol. 2017. PMID: 28742678. doi:10.1097/AOG.0000000000002237
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。